Corrigendum to “Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.” [Neoplasia Volume 23, Issue 9, September 2021, Pages 1002-1015]

IF 4.8 2区医学 Q1 Biochemistry, Genetics and Molecular Biology

Neoplasia Pub Date : 2024-02-24 DOI:10.1016/j.neo.2024.100978

Chinnadurai Mani , Kaushlendra Tripathi , Sandeep Chaudhary , Ranganatha R. Somasagara , Rodney P. Rocconi , Chiquito Crasto , Mark Reedy , Mohammad Athar , Komaraiah Palle

引用次数: 0

查看原文本刊更多论文

Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells：其抑制诱导 HR 缺失和与 PARP 抑制协同致死 "一文的更正。[肿瘤学》第 23 卷第 9 期，2021 年 9 月，第 1002-1015 页］

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neoplasia 医学-肿瘤学

CiteScore

9.20

自引率

2.10%

发文量

审稿时长

26 days

期刊介绍： Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.